Literature DB >> 19549076

Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.

Fabrizio Carta1, Blessy Pothen, Alfonso Maresca, Meena Tiwari, Vineet Singh, Claudiu T Supuran.   

Abstract

Several substituted benzenesulfonamides were synthesized by various pathways starting from sulfanilamide. The sulfanilamide diazonium salt was reacted with copper (I) halides, potassium iodide and/or aromatic derivatives, leading to 4-halogeno-, and 4-hydroxy-benzenesulfonamides as well as diazo dyes incorporating sulfamoyl moieties. These sulfonamides were assayed as inhibitors of two physiologically relevant isoforms of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), i.e., the cytosolic CA II (ubiquitous), and CA VII (brain-specific enzyme). Good CA inhibitory activity was detected for some of these derivatives, with inhibition constants (Ki) in the range of 17.5-863 nm against CA II; and 30-4200 nm against CA VII.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549076     DOI: 10.1111/j.1747-0285.2009.00842.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  Molecular dynamics study of human carbonic anhydrase II in complex with Zn(2+) and acetazolamide on the basis of all-atom force field simulations.

Authors:  Thierry O Wambo; Liao Y Chen; Stanton F McHardy; Andrew T Tsin
Journal:  Biophys Chem       Date:  2016-05-18       Impact factor: 2.352

2.  A Fresh Look at Mouthwashes-What Is Inside and What Is It For?

Authors:  Dominik Radzki; Marta Wilhelm-Węglarz; Katarzyna Pruska; Aida Kusiak; Iwona Ordyniec-Kwaśnica
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390

3.  Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors.

Authors:  Suaad Abdallah Audat; Qosay Ali Al-Balas; Buthina Abdallah Al-Oudat; Mo'ad Jamil Athamneh; Amanda Bryant-Friedrich
Journal:  Drug Des Devel Ther       Date:  2022-03-28       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.